Symbiotec Pharmalab MD and chairman
NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,274.70.
29 Oct: open ₹1,266.10, high ₹1,288.00, low ₹1,236.00
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹8,033 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,68,77644.7% delivered
Symbiotec Pharmalab's chairperson and managing director is Anil Satwani, as filed for the quarter to Sep 2026.
Symbiotec Pharmalab board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorAnil Satwani
- Company Secretary and Compliance OfficerSalil Jain
6 directors3 independent1 executive2 non-executive
- Anil Satwani · Chairperson and managing directorExecutive · joined Sep 2002 · reappointed Jul 2026 · 0 months as independent · 1 listed board · 2 committee seats
- Rohit MantriNominee, non-executive · joined Dec 2018 · 1 listed board
- Sunita KishnaniIndependent · joined Nov 2025 · reappointed Dec 2025 · 10 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 1 as chair
- Pratik PatelIndependent · joined Dec 2025 · reappointed Dec 2025 · 9 months as independent · 2 listed boards · 1 as independent · 4 committee seats, 1 as chair
- Pramod KasatIndependent · joined Jul 2026 · reappointed Aug 2026 · 2 months as independent · 5 listed boards · 5 as independent · 6 committee seats, 1 as chair
- Dhananjay MungaleNominee, non-executive · joined Aug 2026 · 3 listed boards · 3 as independent · 2 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- Hariharnath Buggana, left 5 Aug 2026: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 21 Sep 20265 of 6 present2 independent · 23 days in between
- 28 Aug 20266 of 6 present3 independent · no day in between
- 27 Aug 20265 of 6 present3 independent · 8 days in between
- 18 Aug 20266 of 6 present3 independent · 11 days in between
2 earlier meetings
- 6 Aug 20265 of 5 present3 independent · 36 days in between
- 30 Jun 20265 of 5 present2 independent
Audit Committee
Chair Sunita Kishnani
Anil Satwani, Pratik Patel, Pramod Kasat
- 21 Sep 20263 of 4 present3 independent · 24 days in between
- 27 Aug 20263 of 4 present3 independent · 8 days in between
- 18 Aug 20264 of 4 present3 independent · 11 days in between
- 6 Aug 20263 of 3 present2 independent · 36 days in between
1 earlier meeting
- 30 Jun 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Pratik Patel
Sunita Kishnani, Rohit Mantri
- 6 Aug 20262 of 2 present2 independent · 36 days in between
- 30 Jun 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair Pratik Patel
Sunita Kishnani, Anil Satwani
No meeting listed in the filing.
Risk Management Committee
Chair Anil Satwani
Rohit Mantri, Sunita Kishnani, Raghavender Ramachandran, Salil Jain
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Anil Satwani
Rohit Mantri, Pratik Patel
- 30 Jun 20264 of 4 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- S R B C & CO LLPPeer-review certificate valid to Feb 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.